OR WAIT null SECS
November 14, 2024
Article
In this analysis, the benefits of 2’-FL for mothers’ offspring with regard to allergies were highlighted by investigators.
November 06, 2024
In this review of the month of October, some of the most notable advancements and news in the field of allergy were highlighted.
October 24, 2024
Aquestive Therapeutics plans to submit an NDA for Anaphylm in Q1 2025 based on topline results from the Oral Allergy Syndrome challenge study.
October 17, 2024
Findings from the study also continued to support a positive Ara h 2-sIgE as the single most important predictor of peanut allergy.
October 16, 2024
Incorporating baked milk products into a regular diet may improve growth and quality of life in milk-allergic children.
October 09, 2024
During situations in which those with severe allergies suffer from fatal anaphylaxis, adrenaline autoinjectors were shown in this study to have little effect on such reactions.
These findings highlight the underrepresentation of Black and Hispanic food allergy clinical trial participants and raise concerns about the generalizability of clinical research findings.
October 08, 2024
In the allergy news space, this Month in Review highlights some of the most significant stories covered by the editorial team.
October 03, 2024
Individuals with comorbid asthma and food allergies saw no loss of efficacy in this post hoc analysis, suggesting omalizumab’s potential for such patients.
September 13, 2024
In this analysis, an increased risk of allergy and eczema was associated with bread and thiamine intake increases during pregnancy.
